Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern.
Vergara
Gloria
G
Silvestre
Juan Francisco
JF
Betlloch
Isabel
I
Vela
Paloma
P
Albares
María Pilar
MP
Pascual
José Carlos
JC
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D001707:Biopsy, Needle; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D010328:Patch Tests; D011379:Prognosis; D018570:Risk Assessment
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab